Strong pharmaceutical research capabilities and increasing biotechnology investments are supporting ADC development across North America. Advancements in antibody design, linker technologies, and drug payloads are helping improve the development of next-generation therapies.
Market Overview
The Antibody Drug Conjugates Market is projected to reach US$38,077.45 million by 2031 from US$8,105.65...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek